IVIM Health vs RxActivate: pricing, reviews, and eligibility
Quick verdict: IVIM Health vs RxActivate quickly splits on transparency and social proof. IVIM publishes pricing options, highlights dual 4.9-star Google and Trustpilot ratings, and promotes a proprietary GLP-1 ID protocol; RxActivate requires a two-minute eligibility quiz and contact details before revealing any prices or plan terms.
Start IVIM’s free consult and membership code
How they differ at a glance
When comparing IVIM Health vs RxActivate the most distinctive supported differences are: price and pricing transparency, independent third-party reviews, eligibility gating and lead capture, proprietary program claims, and the documented use of compounded medications. Below we compare these differences directly using only the supplied facts.
Pricing transparency and stated costs
IVIM publishes multiple price points on its page: a listed starting price of $75 and product-level lines showing Semaglutide at $75/mo, Tirzepatide at $133/mo plus a $74.99/mo program fee. The IVIM FAQ also states IVIM Health starts at $99 for the first month and $174/month ongoing, and notes a Free Month Membership with code GIFT75 and a no-obligation free consultation (a $75 value).
Use code GIFT75 for IVIM’s free month details
By contrast, RxActivate does not display prices before the contact-information step. Pricing and billing terms are gated behind completion of a medical eligibility questionnaire and submission of name, email and phone number. The source explicitly states no price, medication fee, membership fee, shipping charge, cancellation term or billing commitment was displayed before the contact-information gate.
Third-party reviews and satisfaction signals
IVIM is shown to have unusually strong third-party validation: a 4.9-star rating on both Google and Trustpilot. The source frames this dual 4.9-star rating as a rare external satisfaction signal among competitors. RxActivate has no captured third-party rating in the supplied evidence; the source did not provide independent review scores.
Eligibility flow and lead capture
RxActivate emphasizes a clinician-matched approach with a two-minute eligibility questionnaire that requests goals, height, weight, timeline, medication history, sex assigned at birth, date of birth, state and safety screening. The flow reported likely eligibility then required personal contact information to reveal plan details. The source confirms Alabama service availability in a synthetic test and that no payment is requested before the contact-information step.
Complete RxActivate’s eligibility quiz
IVIM offers a clinician-guided program with a no-obligation free consultation included for new patients and membership information visible without gated contact entry.
Program claims and evidence
IVIM publishes proprietary outcome claims tied to its GLP-1 ID protocol. The source states IVIM patients following the IVIM Protocol lost an average of 46% more weight over 68 weeks when compared to another published clinical GLP-1 trial and claims the GLP-1 ID protocol can accelerate weight loss outcomes by up to 40% relative to standard protocols. The source preserves these as IVIM protocol claims and notes they are not head-to-head randomized trials and are not independent clinical trial results.
RxActivate’s supplied evidence does not include independent outcome claims or captured provider-published outcome data beyond the platform statement of clinician-matched plans and member count. The source notes provider-published outcome claims are not independent evidence.
Compounded medication status and regulatory notes
Both sources reference compounded medications in context. IVIM explicitly states its offerings include compounded semaglutide and tirzepatide, and repeatedly warns that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. RxActivate notes that medication-specific approval status must be confirmed and that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety and effectiveness.
| Criteria | IVIM Health | RxActivate |
|---|---|---|
| Price visibility | Publishes pricing lines and membership code GIFT75; multiple listed price points and FAQ rates. | Pricing gated behind eligibility quiz and contact form; no prices shown up front. |
| Third-party reviews | 4.9 stars on Google and Trustpilot per source. | No third-party review scores captured in source. |
| Eligibility process | No-contact gate for basic membership info; free consult for new patients. | Two-minute eligibility questionnaire; contact info required to see plans and price. |
| Program claims | Proprietary GLP-1 ID claiming up to 40% faster outcomes and an internal 46% figure; noted as not head-to-head and not independent. | Clinician-matched plans; no captured independent outcome claims in source. |
| Compounded medication note | Uses compounded semaglutide and tirzepatide; states compounded drugs are not FDA-approved. | May offer compounded medications; source notes compounded drugs are not FDA-approved. |
See if you qualify with RxActivate
Which to choose: IVIM Health vs RxActivate
Choose IVIM Health if you value visible pricing, an included no-obligation free consultation and strong third-party review signals. IVIM publishes multiple price lines, a Free Month Membership code GIFT75, a no-obligation $75-value consultation for new patients, and highlights a dual 4.9-star rating on Google and Trustpilot. IVIM also lists proprietary GLP-1 ID protocol claims while clearly marking those claims as internal and noting compounded medication regulatory limitations.
Explore IVIM Health membership and consult
Choose RxActivate if you prefer to confirm clinical eligibility, state availability and tailored medication recommendations before seeing prices. RxActivate requires a two-minute eligibility questionnaire, reports clinician matching, and does not request payment before contact information is provided, but the source shows plan and price details are revealed only after the contact gate.
Both providers note that compounded medications are not FDA-approved and that medication-specific approval or suitability requires clinician review. If a specific gap in the supplied evidence matters to you, such as independent outcome trials for RxActivate or more transparent billing details for RxActivate, that information was not supplied in the sources and should be confirmed directly with each provider.
Primary keyword: IVIM Health vs RxActivate